Does sticking to growth hormone treatment help kids grow taller? study aims to find out.
NCT ID NCT03972345
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at children and teenagers with growth hormone deficiency or who were born small for their age. It tracks how closely they follow their prescribed Norditropin® treatment and whether that affects their final height. The study is observational, meaning no new treatment is given—participants just continue their normal care. Up to 750 children in Germany will be followed for up to 10 years.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BORN SMALL FOR GESTATIONAL AGE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Uniklinik Ulm - Dt. Zentrum für Kinder- und Jugendgesundheit (DZKJ)
Ulm, 89075, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New growth hormone treatment for short children enters final testing phase
- New growth hormone drug sogroya® tracked in kids for up to 3 years
- Weekly shot could replace daily needles for kids with growth hormone deficiency
- Once-a-Week needle could replace daily pokes for growth hormone deficiency
- Weekly shot may replace daily needle for kids with growth hormone deficiency